| abstract |
The invention relates to a novel tetrahydrochinoline derivative, a method for the production thereof, the use thereof either alone in or in combinations for the treatment and/or prevention of illnesses, in addition to the use thereof in the production of medicaments, particularly as an inhibitor of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular diseases, particularly hypolipoproteinemias, dyslipidemias, hypertriglyceridemias, hyperlipidemias, hypercholesterolemias and arteriosklerosis. |